Agree good time to take advantage of SP. I own a business in B2B sales and the lead times are long - Spenda is a major implementation and purchase for a business so its going to go through many hoops firsts, and then many signoffs with most boards having the final say. Boards don't meet regularly and rarely make a decision on the first meeting. And good luck getting a meeting let alone a decision during lockdowns
What I was more interested in was the increase in spend on sales and marketing. It will be the pipeline that I'd be interested in seeing, as this will have a direct correlation to future sales. I'd like them to spend more on sales.
In hindsight this qtr was never ever going to be good due to the sales lead time, lockdowns and Spenda just being launched. Next qtr may not be as good as people are expecting either, however Whola has highlighted how 1 company can change this and what income CRO can make! (Capricorn and Carpet Court maybe?) What has strengthened my conviction in the company is the deal with Whola as we now know it works and works bloody well - along with providing significant income. Now throw in MC relationship and you can see why people are very bullish for CRO
I'm taking the punt this company will be a unicorn but they don't happen overnight - this product is unique, a disrupter and Global. And unlike some unicorns i believe can be profitable quickly while still maintaining strong growth. Give the sales team time to build their pipeline but once the are fully humming, watch the deals start coming in - we need to give them that time to deliver after all. And stop expecting to be millionaires overnight!
- Forums
- ASX - By Stock
- SPX
- Ann: Quarterly Appendix 4C Cash Flow Report
Ann: Quarterly Appendix 4C Cash Flow Report, page-126
Featured News
Add SPX (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $55.24M |
Open | High | Low | Value | Volume |
1.1¢ | 1.2¢ | 1.1¢ | $9.396K | 854.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 13826610 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 3486919 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 13826610 | 0.011 |
19 | 8123556 | 0.010 |
8 | 4185107 | 0.009 |
3 | 10124931 | 0.008 |
3 | 5232562 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 3486919 | 8 |
0.013 | 5291890 | 14 |
0.014 | 6935295 | 20 |
0.015 | 2122316 | 8 |
0.016 | 6251500 | 4 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
SPX (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online